AmerisourceBergen to Acquire PharmaLex for ~$1.30B
Shots:
- AmerisourceBergen to acquire PharmaLex for ~$1.30B in cash using funds advised by AUCTUS capital partners. The transaction is expected to close in March 2023
- The acquisition will accelerate AmerisourceBergen’s global biopharma services platform to support manufacturer partners across pharmaceutical development & commercialization. PharmaLex provides biopharma companies strategic guidance & regulatory support, incl. consulting during clinical development & marketing authorization
- AmerisourceBergen has a presence in the EU for pharmaceutical distribution and manufacturer services for biopharma products while AmerisourceBergen's imperatives will be advanced & will strengthen the company's position in the biopharma market
Ref: Businesswire | Image: PharmaLex
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
